Glaucoma is a stealthy illness; most people have no early symptoms and do not notice as their peripheral vision diminishes or blind spots occur. As a result, about half of the three million Americans with the disease are unaware of their condition.
Early detection is critical to maintain healthy vision. With almost two-thirds of adult Americans, who do not wear corrective lenses, not receiving regular comprehensive eye exams, millions of people are putting their vision and their quality of life at risk, according to the American Optometric Association.
The Defense Advanced Projects Agency (DARPA) has selected Goodrich Corporation to develop next-generation night vision sensor technology for helmet-mounted and micro vehicle applications.
Varian Medical Systems has received FDA 510(k) clearances for its RapidArc(TM) radiotherapy technology, a revolutionary advance that makes it possible to deliver image-guided, intensity-modulated radiation therapy (IMRT) two to eight times faster and more precisely than is possible with conventional IMRT or helical tomotherapy.
QPC Lasers, a company in the development and commercialization of high brightness, high power semiconductor lasers for the consumer, industrial, defense, and medical markets, announced that it has won a major contract to develop and deliver lasers to be used in rear projection televisions based on DLP and LCOS technologies.
NeuroMetrix, Inc., a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and pain, announced today that it has acquired substantially all of the assets of EyeTel Imaging, Inc. and has assumed certain specified liabilities in connection with the acquisition.
Laser surgery to correct vision problems has been in use since the early 1990s. Photorefractive Keratotomy (PRK) is typically used to correct low to moderate myopia, while laser in-situ keratomileusis (LASIK) is preferred for high myopia corrections. Although over 18 million LASIK procedures have been performed worldwide, there is still some controversy regarding the maximum correction possible and efficacy with this technique.
In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38% to 52% of the total.
Medicsight PLC, a subsidiary of MGT Capital Investments, Inc., and an industry leader in the development of Computer-Aided Detection (CAD) and image analysis software which assists in the early detection of disease, welcomes the initiative by Barbara Cubin, Republican Representative for Wyoming, to introduce legislation to increase patient access to Computed Tomography Colonography (CTC). CTC is the innovative screening test for colorectal cancer that has the potential to save thousands of lives.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced an agreement with The Gillette Company (a wholly owned subsidiary of The Procter and Gamble Company) to extend the Launch Decision of a home-use, light-based hair removal device for women until no later than February 29, 2008.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.